Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 2 5Phase 3 4Phase 1 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1Genitourinary 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Prostatic Neoplasms 1

Interventions

Cyclophosphamide 415Radiotherapy 274fludarabine 237Gemcitabine 210Cisplatin 202Nivolumab 184pembrolizumab 181Paclitaxel 176Carboplatin 167Magnetic Resonance Spectroscopy 163fludarabine phosphate 156Irinotecan 134Bevacizumab 133Cytarabine 128Capecitabine 124Temozolomide 123Specimen Handling 122Radiosurgery 117Docetaxel 116Biopsy 115Ipilimumab 114Dexamethasone 113Radiation 109Oxaliplatin 109Fluorouracil 109Etoposide 108Rituximab 107Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Selenium × Clear all
NCT00112892 2014-01-13

Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors

Roswell Park Cancer Institute

Phase 1 Completed
36 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00217516 2012-02-09

Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer

Roswell Park Cancer Institute

Phase 1 Completed
18 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡